Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Fosfocreatine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MVD | P53602 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fosfocreatine SCHEMBL65425 | 0.98 | MVD (0.44) | MVD | |
| Fosfocreatine SCHEMBL24116748 | 0.98 | MVD (0.44) | MVD | |
| Fosfocreatine SCHEMBL2124030 | 0.98 | MVD (0.44) | MVD | |
| Fosfocreatine SCHEMBL453327 | 0.92 | MVD (0.38) | MVD | |
| Fosfocreatine SCHEMBL5248692 | 0.90 | MVD (0.39) | MVD | |
| Fosfocreatine SCHEMBL9075223 | 0.90 | MVD (0.39) | MVD | |
| Fosfocreatine SCHEMBL29526710 | 0.87 | MVD (0.37) | MVD | |
| Fosfocreatine SCHEMBL29749874 | 0.81 | MVD (0.40) | MVD | |
| Fosfocreatine SCHEMBL1640494 | 0.80 | MVD (0.38) | MVD | |
| Fosfocreatine SCHEMBL30031412 | 0.80 | MVD (0.38) | MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690858-B1 | Neuroprotective mixture for mitigating the harmful effects of ischemic stroke | TRICERAPRO HOLDING, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-10864221-B1 | Neuroprotective mixture for mitigating the harmful effects of ischemic stroke | TRICERAPRO HOLDING, LLC (US) | 2020-12-15 | — | — | US | disclosed |
| US-20130281410-A1 | METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2013-10-24 | — | — | US | disclosed |
| WO-2011143534-A1 | METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | THE MCLEAN HOSPITAL CORPORATION (US) | 2011-11-17 | — | — | WO | disclosed |